Effectiveness and safety of ixazomib-lenalidomide--dexamethasone in high-cytogenetic-risk relapsed//refractory multiple myeloma -- results of the Polish Myeloma Group observational study.
| Autor: | Hus, Marek, Szudy-Szczyrek, Aneta, Mielnik, Michał, Bernatowicz, Paweł Leszek, Piszcz, Jarosław, Druzd-Sitek, Agnieszka, Czyżewska, Maria, Putowski, Maciej, Giannopoulos, Krzysztof |
|---|---|
| Zdroj: | Hematology in Clinical Practice; 2021, Vol. 31 Issue 1, p8-17, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|